Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
19.73
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
19.39
-0.34 (-1.72%)
After-hours: Nov 13, 2026, 7:59 PM EST

Hims & Hers Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-190.84128.37126.04-23.55-65.68-107.66
Depreciation & Amortization
107.7354.517.099.527.474.08
Other Amortization
7.734.53---0.14
Asset Writedown & Restructuring Costs
29.610.530.110.431.13-
Loss (Gain) From Sale of Investments
-21.51-6.47-4.36-5.690.152.17
Stock-Based Compensation
177.94135.2492.3266.0842.8267.21
Other Operating Activities
49.8212.47-58.755.871.78-3.8
Change in Inventory
-8.84-13.72-41.61-0.9-8-9.63
Change in Accounts Payable
305.3930.343.717.3212.729.85
Change in Unearned Revenue
13.7251.667.556.26-1.721.41
Change in Other Net Operating Assets
17.18-97.348.978.14-17.21.82
Operating Cash Flow
180.12300.01251.0873.48-26.53-34.41
Operating Cash Flow Growth
-44.59%19.48%241.69%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-148.44-226.05-41.66-17.22-2.71-0.83
Cash Acquisitions
-471.91-145.23-15.4--0.46-46.47
Sale (Purchase) of Intangibles
-33.44-16.55-11.1-9.27-4.53-4.18
Investment in Securities
583.78-637.1449.114.3942.41-104.79
Investing Cash Flow
-70.01-1,025-19.05-12.1134.7-156.27

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-970----
Net Debt Issued (Repaid)
390.43970----
Issuance of Common Stock
21.8417.4730.894.623.42275.92
Repurchase of Common Stock
-183.43-206.63-135.54-16.1-3.9-28.03
Other Financing Activities
-81.4-51.22-3.19--32.65-12.85
Financing Cash Flow
147.43729.62-107.85-11.48-33.13235.04

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2.282.51-0.27-0.01-0.05-0.07
Net Cash Flow
259.837.18123.9249.89-25.0144.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
31.6873.96209.4356.26-29.25-35.24
Free Cash Flow Growth
-76.34%-64.68%272.23%---
Free Cash Flow Margin
1.10%3.15%14.18%6.45%-5.55%-12.96%
Free Cash Flow Per Share
0.140.290.880.27-0.14-0.19
Levered Free Cash Flow
573.2110.51178.6266.38-44.3552.46
Unlevered Free Cash Flow
573.62108.42178.6266.38-44.3552.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.12-----
Cash Income Tax Paid
-23.167.921.110.640.34
Change in Working Capital
19.65-29.1678.6220.82-14.23.46
SEC Filings: 10-K · 10-Q